Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06950593 · ClinicalTrials.gov registry record · NA

Transcutaneous Electrical Stimulation for Stroke Patients

A NA study of Upper Limb Hemiparesis Following Stroke, sponsored by Shirley Ryan AbilityLab.

Recruiting
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT06950593 is a NA study of Upper Limb Hemiparesis Following Stroke that is actively recruiting participants, run by Shirley Ryan AbilityLab. The registered enrollment target is 14 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06950593, a NA study of Upper Limb Hemiparesis Following Stroke, is actively recruiting participants, sponsored by Shirley Ryan AbilityLab.

RECRUITING
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

This study aims to evaluate the feasibility and impact of transcutaneous electrical stimulation of the spinal cord (TESS) on the recovery of post-stroke individuals who have upper limb hemiparesis. It will compare outcomes measures between individuals who receive upper limb task specific training with TESS and individuals who receive task specific training of the upper limb with Sham, or fake, TESS.

Interventions

  • OTHER Task Specific Training (TST)
  • OTHER Transcutaneous electrical spinal cord stimulation (TESS)
  • OTHER Sham transcutaneous electrical spinal cord stimulation (Sham TESS)

Study Locations (1)

Illinois

  • Shirley Ryan AbilityLab - Chicago

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2025-08-18
Est. Completion 2027-01-01
Phase NA

Sponsor

Shirley Ryan AbilityLab

138 total trials

What the Registry Record Tells You About NCT06950593

The ClinicalTrials.gov registry entry for NCT06950593 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Upper Limb Hemiparesis Following Stroke appearing as the primary indexed condition, and to 3 interventions - of which Task Specific Training (TST) is the first listed.

NCT06950593 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06950593 about?

NCT06950593 is a clinical study titled "Transcutaneous Electrical Stimulation for Stroke Patients". This study aims to evaluate the feasibility and impact of transcutaneous electrical stimulation of the spinal cord (TESS) on the recovery of post-stroke individuals who have upper limb hemiparesis. It will compare outcomes measures between individuals who receive upper limb task specific training wi...

What is the current status of trial NCT06950593?

This trial is currently recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2025-08-18. Estimated completion is 2027-01-01.

What conditions does trial NCT06950593 study?

This clinical trial studies the following conditions: Upper Limb Hemiparesis Following Stroke.

What interventions are being tested in trial NCT06950593?

The interventions under investigation include: Task Specific Training (TST) (OTHER), Transcutaneous electrical spinal cord stimulation (TESS) (OTHER), Sham transcutaneous electrical spinal cord stimulation (Sham TESS) (OTHER).

Who is sponsoring clinical trial NCT06950593?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06950593 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.